Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease

CONCLUSION: Sofosbuvir-based DAA therapy is a highly effective and safe treatment regimen that results in the improvement of platelet count in thrombocytopenic patients, particularly in mild to moderate stages of hepatic fibrosis.PMID:34122539 | PMC:PMC8169259 | DOI:10.1155/2021/8811203

Source: Gastroenterology Research and Practice - June 14, 2021 Category: Gastroenterology Authors: Mahmoud Saif-Al-Islam Usama M Abdelaal Mustafa Adel Younis Hisham A Alghany Algahlan Safaa Khalaf Source Type: research